APO Research
Talk to an analyst

APO RESEARCH · REPORT

Histone Deacetylase 1

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Histone Deacetylase 1 Market Outlook and Growth Opportunities 2026

19 December 2025195 pages

Choose your research edition.

Industry ResearchHistone Deacetylase 1 Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Histone Deacetylase 1 Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Histone Deacetylase 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Histone Deacetylase 1 Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Histone Deacetylase 1 Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Histone Deacetylase 1 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Histone Deacetylase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Histone Deacetylase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Histone Deacetylase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Histone Deacetylase 1 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Histone Deacetylase 1 market include 4SC AG, Acetylon Pharmaceuticals, Inc., Chipscreen Biosciences Ltd, Curis, Inc., HitGen LTD, IRBM Science Park SpA, Italfarmaco S.p.A., MEI Pharma, Inc. and Mirati Therapeutics Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Histone Deacetylase 1 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Histone Deacetylase 1 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Histone Deacetylase 1 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Histone Deacetylase 1 market size, projected growth trends, production technologies, key applications, and end-use industries.

Histone Deacetylase 1 Segment by Company

4SC AG

Acetylon Pharmaceuticals, Inc.

Chipscreen Biosciences Ltd

Curis, Inc.

HitGen LTD

IRBM Science Park SpA

Italfarmaco S.p.A.

MEI Pharma, Inc.

Mirati Therapeutics Inc.

Oncolys BioPharma Inc.

Sigma-Tau S.p.A.

Syndax Pharmaceuticals, Inc.

TetraLogic Pharmaceuticals

GlaxoSmithKline Plc

Merck & Co., Inc.

Histone Deacetylase 1 Segment by Type

ST-3595

RCY-1305

HG-3001

CS-3158

ACY-957

Others

Histone Deacetylase 1 Segment by Application

Myelofibrosis

Skin Cancer

Neurology

Alopecia

Endometrial Cancer

Others

Histone Deacetylase 1 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Histone Deacetylase 1 status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Histone Deacetylase 1 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Histone Deacetylase 1 significant trends, drivers, influence factors in global and regions.

6. To analyze Histone Deacetylase 1 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Histone Deacetylase 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Histone Deacetylase 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Histone Deacetylase 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Histone Deacetylase 1 market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Histone Deacetylase 1 industry.

Chapter 3: Detailed analysis of Histone Deacetylase 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Histone Deacetylase 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Histone Deacetylase 1 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Histone Deacetylase 1 Industry Trends Table 2. Histone Deacetylase 1 Industry Drivers Table 3. Histone Deacetylase 1 Industry Opportunities and Challenges Table 4. Histone Deacetylase 1 Industry Restraints Table 5. Global Histone Deacetylase 1 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Histone Deacetylase 1 Revenue Share by Company (2021-2026) Table 7. Global Histone Deacetylase 1 Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Histone Deacetylase 1 Sales Volume Share by Company (2021-2026) Table 9. Global Histone Deacetylase 1 Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Histone Deacetylase 1 Company Ranking, (2024-2026) & (USD Million) Table 11. Global Histone Deacetylase 1 Key Company Manufacturing Base & Headquarters Table 12. Global Histone Deacetylase 1 Company, Product Type & Application Table 13. Global Histone Deacetylase 1 Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Histone Deacetylase 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of ST-3595 Table 18. Significant Companies of RCY-1305 Table 19. Significant Companies of HG-3001 Table 20. Significant Companies of CS-3158 Table 21. Significant Companies of ACY-957 Table 22. Significant Companies of Others Table 23. Global Histone Deacetylase 1 Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Histone Deacetylase 1 Sales Volume by Type (2021-2026) & (K Units) Table 25. Global Histone Deacetylase 1 Sales Volume by Type (2027-2032) & (K Units) Table 26. Global Histone Deacetylase 1 Sales Volume Share by Type (2021-2026) Table 27. Global Histone Deacetylase 1 Sales Volume Share by Type (2027-2032) Table 28. Global Histone Deacetylase 1 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Histone Deacetylase 1 Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Histone Deacetylase 1 Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Histone Deacetylase 1 Sales Value Share by Type (2021-2026) Table 32. Global Histone Deacetylase 1 Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Myelofibrosis Table 34. Significant Companies of Skin Cancer Table 35. Significant Companies of Neurology Table 36. Significant Companies of Alopecia Table 37. Significant Companies of Endometrial Cancer Table 38. Significant Companies of Others Table 39. Global Histone Deacetylase 1 Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Histone Deacetylase 1 Sales Volume by Application (2021-2026) & (K Units) Table 41. Global Histone Deacetylase 1 Sales Volume by Application (2027-2032) & (K Units) Table 42. Global Histone Deacetylase 1 Sales Volume Share by Application (2021-2026) Table 43. Global Histone Deacetylase 1 Sales Volume Share by Application (2027-2032) Table 44. Global Histone Deacetylase 1 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Histone Deacetylase 1 Sales Value by Application (2021-2026) & (US$ Million) Table 46. Global Histone Deacetylase 1 Sales Value by Application (2027-2032) & (US$ Million) Table 47. Global Histone Deacetylase 1 Sales Value Share by Application (2021-2026) Table 48. Global Histone Deacetylase 1 Sales Value Share by Application (2027-2032) Table 49. Global Histone Deacetylase 1 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 50. Global Histone Deacetylase 1 Sales by Region (2021-2026) & (K Units) Table 51. Global Histone Deacetylase 1 Sales Market Share by Region (2021-2026) Table 52. Global Histone Deacetylase 1 Sales by Region (2027-2032) & (K Units) Table 53. Global Histone Deacetylase 1 Sales Market Share by Region (2027-2032) Table 54. Global Histone Deacetylase 1 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Histone Deacetylase 1 Sales Value by Region (2021-2026) & (US$ Million) Table 56. Global Histone Deacetylase 1 Sales Value Share by Region (2021-2026) Table 57. Global Histone Deacetylase 1 Sales Value by Region (2027-2032) & (US$ Million) Table 58. Global Histone Deacetylase 1 Sales Value Share by Region (2027-2032) Table 59. Global Histone Deacetylase 1 Market Average Price (US$/Unit) by Region (2021-2026) Table 60. Global Histone Deacetylase 1 Market Average Price (US$/Unit) by Region (2027-2032) Table 61. Global Histone Deacetylase 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 62. Global Histone Deacetylase 1 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Histone Deacetylase 1 Sales by Country (2021-2026) & (K Units) Table 64. Global Histone Deacetylase 1 Sales Market Share by Country (2021-2026) Table 65. Global Histone Deacetylase 1 Sales by Country (2027-2032) & (K Units) Table 66. Global Histone Deacetylase 1 Sales Market Share by Country (2027-2032) Table 67. Global Histone Deacetylase 1 Sales Value by Country (2021-2026) & (US$ Million) Table 68. Global Histone Deacetylase 1 Sales Value Market Share by Country (2021-2026) Table 69. Global Histone Deacetylase 1 Sales Value by Country (2027-2032) & (US$ Million) Table 70. Global Histone Deacetylase 1 Sales Value Market Share by Country (2027-2032) Table 71. 4SC AG Company Information Table 72. 4SC AG Business Overview Table 73. 4SC AG Histone Deacetylase 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. 4SC AG Histone Deacetylase 1 Product Portfolio Table 75. 4SC AG Recent Development Table 76. Acetylon Pharmaceuticals, Inc. Company Information Table 77. Acetylon Pharmaceuticals, Inc. Business Overview Table 78. Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 Product Portfolio Table 80. Acetylon Pharmaceuticals, Inc. Recent Development Table 81. Chipscreen Biosciences Ltd Company Information Table 82. Chipscreen Biosciences Ltd Business Overview Table 83. Chipscreen Biosciences Ltd Histone Deacetylase 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Chipscreen Biosciences Ltd Histone Deacetylase 1 Product Portfolio Table 85. Chipscreen Biosciences Ltd Recent Development Table 86. Curis, Inc. Company Information Table 87. Curis, Inc. Business Overview Table 88. Curis, Inc. Histone Deacetylase 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Curis, Inc. Histone Deacetylase 1 Product Portfolio Table 90. Curis, Inc. Recent Development Table 91. HitGen LTD Company Information Table 92. HitGen LTD Business Overview Table 93. HitGen LTD Histone Deacetylase 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. HitGen LTD Histone Deacetylase 1 Product Portfolio Table 95. HitGen LTD Recent Development Table 96. IRBM Science Park SpA Company Information Table 97. IRBM Science Park SpA Business Overview Table 98. IRBM Science Park SpA Histone Deacetylase 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. IRBM Science Park SpA Histone Deacetylase 1 Product Portfolio Table 100. IRBM Science Park SpA Recent Development Table 101. Italfarmaco S.p.A. Company Information Table 102. Italfarmaco S.p.A. Business Overview Table 103. Italfarmaco S.p.A. Histone Deacetylase 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Italfarmaco S.p.A. Histone Deacetylase 1 Product Portfolio Table 105. Italfarmaco S.p.A. Recent Development Table 106. MEI Pharma, Inc. Company Information Table 107. MEI Pharma, Inc. Business Overview Table 108. MEI Pharma, Inc. Histone Deacetylase 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. MEI Pharma, Inc. Histone Deacetylase 1 Product Portfolio Table 110. MEI Pharma, Inc. Recent Development Table 111. Mirati Therapeutics Inc. Company Information Table 112. Mirati Therapeutics Inc. Business Overview Table 113. Mirati Therapeutics Inc. Histone Deacetylase 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Mirati Therapeutics Inc. Histone Deacetylase 1 Product Portfolio Table 115. Mirati Therapeutics Inc. Recent Development Table 116. Oncolys BioPharma Inc. Company Information Table 117. Oncolys BioPharma Inc. Business Overview Table 118. Oncolys BioPharma Inc. Histone Deacetylase 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Oncolys BioPharma Inc. Histone Deacetylase 1 Product Portfolio Table 120. Oncolys BioPharma Inc. Recent Development Table 121. Sigma-Tau S.p.A. Company Information Table 122. Sigma-Tau S.p.A. Business Overview Table 123. Sigma-Tau S.p.A. Histone Deacetylase 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Sigma-Tau S.p.A. Histone Deacetylase 1 Product Portfolio Table 125. Sigma-Tau S.p.A. Recent Development Table 126. Syndax Pharmaceuticals, Inc. Company Information Table 127. Syndax Pharmaceuticals, Inc. Business Overview Table 128. Syndax Pharmaceuticals, Inc. Histone Deacetylase 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Syndax Pharmaceuticals, Inc. Histone Deacetylase 1 Product Portfolio Table 130. Syndax Pharmaceuticals, Inc. Recent Development Table 131. TetraLogic Pharmaceuticals Company Information Table 132. TetraLogic Pharmaceuticals Business Overview Table 133. TetraLogic Pharmaceuticals Histone Deacetylase 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. TetraLogic Pharmaceuticals Histone Deacetylase 1 Product Portfolio Table 135. TetraLogic Pharmaceuticals Recent Development Table 136. GlaxoSmithKline Plc Company Information Table 137. GlaxoSmithKline Plc Business Overview Table 138. GlaxoSmithKline Plc Histone Deacetylase 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. GlaxoSmithKline Plc Histone Deacetylase 1 Product Portfolio Table 140. GlaxoSmithKline Plc Recent Development Table 141. Merck & Co., Inc. Company Information Table 142. Merck & Co., Inc. Business Overview Table 143. Merck & Co., Inc. Histone Deacetylase 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Merck & Co., Inc. Histone Deacetylase 1 Product Portfolio Table 145. Merck & Co., Inc. Recent Development Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Histone Deacetylase 1 Distributors List Table 149. Histone Deacetylase 1 Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Histone Deacetylase 1 Product Image Figure 2. Global Histone Deacetylase 1 Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Histone Deacetylase 1 Sales Value (2021-2032) & (US$ Million) Figure 4. Global Histone Deacetylase 1 Sales (2021-2032) & (K Units) Figure 5. Global Histone Deacetylase 1 Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Histone Deacetylase 1 Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. ST-3595 Image Figure 10. RCY-1305 Image Figure 11. HG-3001 Image Figure 12. CS-3158 Image Figure 13. ACY-957 Image Figure 14. Others Image Figure 15. Global Histone Deacetylase 1 Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Histone Deacetylase 1 Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Histone Deacetylase 1 Sales Volume Share by Type (2021-2032) Figure 18. Global Histone Deacetylase 1 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Histone Deacetylase 1 Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Histone Deacetylase 1 Sales Value Share by Type (2021-2032) Figure 21. Myelofibrosis Image Figure 22. Skin Cancer Image Figure 23. Neurology Image Figure 24. Alopecia Image Figure 25. Endometrial Cancer Image Figure 26. Others Image Figure 27. Global Histone Deacetylase 1 Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Histone Deacetylase 1 Sales Volume Share 2021 VS 2025 VS 2032 Figure 29. Global Histone Deacetylase 1 Sales Volume Share by Application (2021-2032) Figure 30. Global Histone Deacetylase 1 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Histone Deacetylase 1 Sales Value Share 2021 VS 2025 VS 2032 Figure 32. Global Histone Deacetylase 1 Sales Value Share by Application (2021-2032) Figure 33. Global Histone Deacetylase 1 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 34. Global Histone Deacetylase 1 Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 35. Global Histone Deacetylase 1 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 36. Global Histone Deacetylase 1 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 37. North America Histone Deacetylase 1 Sales Value (2021-2032) & (US$ Million) Figure 38. North America Histone Deacetylase 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Europe Histone Deacetylase 1 Sales Value (2021-2032) & (US$ Million) Figure 40. Europe Histone Deacetylase 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Asia-Pacific Histone Deacetylase 1 Sales Value (2021-2032) & (US$ Million) Figure 42. Asia-Pacific Histone Deacetylase 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 43. South America Histone Deacetylase 1 Sales Value (2021-2032) & (US$ Million) Figure 44. South America Histone Deacetylase 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 45. Middle East & Africa Histone Deacetylase 1 Sales Value (2021-2032) & (US$ Million) Figure 46. Middle East & Africa Histone Deacetylase 1 Sales Value Share by Country (%), 2025 VS 2032 Figure 47. USA Histone Deacetylase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. USA Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. USA Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Canada Histone Deacetylase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Canada Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Canada Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Mexico Histone Deacetylase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Mexico Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Mexico Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Germany Histone Deacetylase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Germany Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Germany Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. France Histone Deacetylase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. France Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. France Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. U.K. Histone Deacetylase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. U.K. Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. U.K. Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Italy Histone Deacetylase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Italy Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Italy Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Spain Histone Deacetylase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Spain Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Spain Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Russia Histone Deacetylase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Russia Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Russia Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Netherlands Histone Deacetylase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Netherlands Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Netherlands Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Nordic Countries Histone Deacetylase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Nordic Countries Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Nordic Countries Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. China Histone Deacetylase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. China Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. China Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Japan Histone Deacetylase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Japan Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Japan Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. South Korea Histone Deacetylase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. South Korea Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. South Korea Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. India Histone Deacetylase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. India Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. India Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Australia Histone Deacetylase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Australia Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Australia Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Southeast Asia Histone Deacetylase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Southeast Asia Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Southeast Asia Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Brazil Histone Deacetylase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Brazil Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Brazil Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Argentina Histone Deacetylase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Argentina Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Argentina Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Chile Histone Deacetylase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Chile Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Chile Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Colombia Histone Deacetylase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Colombia Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Colombia Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Peru Histone Deacetylase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Peru Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Peru Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Histone Deacetylase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Saudi Arabia Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Saudi Arabia Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Israel Histone Deacetylase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Israel Arabia Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Israel Arabia Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. UAE Histone Deacetylase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. UAE Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. UAE Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Turkey Histone Deacetylase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Turkey Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Turkey Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Iran Histone Deacetylase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Iran Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Iran Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Egypt Histone Deacetylase 1 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 129. Egypt Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 130. Egypt Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 131. Histone Deacetylase 1 Value Chain Figure 132. Manufacturing Cost Structure Figure 133. Histone Deacetylase 1 Sales Mode & Process Figure 134. Direct Comparison with Distribution Share Figure 135. Distributors Profiles Figure 136. Years Considered Figure 137. Research Process Figure 138. Key Executives Interviewed

Scope & coverage.

Types
  • ST-3595
  • RCY-1305
  • HG-3001
  • CS-3158
  • ACY-957
  • Others
Applications
  • Myelofibrosis
  • Skin Cancer
  • Neurology
  • Alopecia
  • Endometrial Cancer
  • Others
Companies covered
  • 4SC AG
  • Acetylon Pharmaceuticals, Inc.
  • Chipscreen Biosciences Ltd
  • Curis, Inc.
  • HitGen LTD
  • IRBM Science Park SpA
  • Italfarmaco S.p.A.
  • MEI Pharma, Inc.
  • Mirati Therapeutics Inc.
  • Oncolys BioPharma Inc.
  • Sigma-Tau S.p.A.
  • Syndax Pharmaceuticals, Inc.
  • TetraLogic Pharmaceuticals
  • GlaxoSmithKline Plc
  • Merck & Co., Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Histone Deacetylase 1 Sales Value (2021-2032)
  4. 1.2.2 Global Histone Deacetylase 1 Sales Volume (2021-2032)
  5. 1.2.3 Global Histone Deacetylase 1 Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Histone Deacetylase 1 Market Dynamics
  1. 2.1 Histone Deacetylase 1 Industry Trends
  2. 2.2 Histone Deacetylase 1 Industry Drivers
  3. 2.3 Histone Deacetylase 1 Industry Opportunities and Challenges
  4. 2.4 Histone Deacetylase 1 Industry Restraints
3 Histone Deacetylase 1 Market by Company
  1. 3.1 Global Histone Deacetylase 1 Company Revenue Ranking in 2025
  2. 3.2 Global Histone Deacetylase 1 Revenue by Company (2021-2026)
  3. 3.3 Global Histone Deacetylase 1 Sales Volume by Company (2021-2026)
  4. 3.4 Global Histone Deacetylase 1 Average Price by Company (2021-2026)
  5. 3.5 Global Histone Deacetylase 1 Company Ranking (2024-2026)
  6. 3.6 Global Histone Deacetylase 1 Company Manufacturing Base and Headquarters
  7. 3.7 Global Histone Deacetylase 1 Company Product Type and Application
  8. 3.8 Global Histone Deacetylase 1 Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Histone Deacetylase 1 Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Histone Deacetylase 1 Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Histone Deacetylase 1 Market by Type
  1. 4.1 Histone Deacetylase 1 Type Introduction
  2. 4.1.1 ST-3595
  3. 4.1.2 RCY-1305
  4. 4.1.3 HG-3001
  5. 4.1.4 CS-3158
  6. 4.1.5 ACY-957
  7. 4.1.6 Others
  8. 4.2 Global Histone Deacetylase 1 Sales Volume by Type
  9. 4.2.1 Global Histone Deacetylase 1 Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Histone Deacetylase 1 Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Histone Deacetylase 1 Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Histone Deacetylase 1 Sales Value by Type
  13. 4.3.1 Global Histone Deacetylase 1 Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Histone Deacetylase 1 Sales Value by Type (2021-2032)
  15. 4.3.3 Global Histone Deacetylase 1 Sales Value Share by Type (2021-2032)
5 Histone Deacetylase 1 Market by Application
  1. 5.1 Histone Deacetylase 1 Application Introduction
  2. 5.1.1 Myelofibrosis
  3. 5.1.2 Skin Cancer
  4. 5.1.3 Neurology
  5. 5.1.4 Alopecia
  6. 5.1.5 Endometrial Cancer
  7. 5.1.6 Others
  8. 5.2 Global Histone Deacetylase 1 Sales Volume by Application
  9. 5.2.1 Global Histone Deacetylase 1 Sales Volume by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Histone Deacetylase 1 Sales Volume by Application (2021-2032)
  11. 5.2.3 Global Histone Deacetylase 1 Sales Volume Share by Application (2021-2032)
  12. 5.3 Global Histone Deacetylase 1 Sales Value by Application
  13. 5.3.1 Global Histone Deacetylase 1 Sales Value by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Histone Deacetylase 1 Sales Value by Application (2021-2032)
  15. 5.3.3 Global Histone Deacetylase 1 Sales Value Share by Application (2021-2032)
6 Histone Deacetylase 1 Regional Sales and Value Analysis
  1. 6.1 Global Histone Deacetylase 1 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Histone Deacetylase 1 Sales by Region (2021-2032)
  3. 6.2.1 Global Histone Deacetylase 1 Sales by Region: 2021-2026
  4. 6.2.2 Global Histone Deacetylase 1 Sales by Region (2027-2032)
  5. 6.3 Global Histone Deacetylase 1 Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Histone Deacetylase 1 Sales Value by Region (2021-2032)
  7. 6.4.1 Global Histone Deacetylase 1 Sales Value by Region: 2021-2026
  8. 6.4.2 Global Histone Deacetylase 1 Sales Value by Region (2027-2032)
  9. 6.5 Global Histone Deacetylase 1 Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Histone Deacetylase 1 Sales Value (2021-2032)
  12. 6.6.2 North America Histone Deacetylase 1 Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Histone Deacetylase 1 Sales Value (2021-2032)
  15. 6.7.2 Europe Histone Deacetylase 1 Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Histone Deacetylase 1 Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Histone Deacetylase 1 Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Histone Deacetylase 1 Sales Value (2021-2032)
  21. 6.9.2 South America Histone Deacetylase 1 Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Histone Deacetylase 1 Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Histone Deacetylase 1 Sales Value Share by Country, 2025 VS 2032
7 Histone Deacetylase 1 Country-level Sales and Value Analysis
  1. 7.1 Global Histone Deacetylase 1 Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Histone Deacetylase 1 Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Histone Deacetylase 1 Sales by Country (2021-2032)
  4. 7.3.1 Global Histone Deacetylase 1 Sales by Country (2021-2026)
  5. 7.3.2 Global Histone Deacetylase 1 Sales by Country (2027-2032)
  6. 7.4 Global Histone Deacetylase 1 Sales Value by Country (2021-2032)
  7. 7.4.1 Global Histone Deacetylase 1 Sales Value by Country (2021-2026)
  8. 7.4.2 Global Histone Deacetylase 1 Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Histone Deacetylase 1 Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Histone Deacetylase 1 Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Histone Deacetylase 1 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Histone Deacetylase 1 Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Histone Deacetylase 1 Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Histone Deacetylase 1 Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Histone Deacetylase 1 Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Histone Deacetylase 1 Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Histone Deacetylase 1 Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Histone Deacetylase 1 Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Histone Deacetylase 1 Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Histone Deacetylase 1 Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Histone Deacetylase 1 Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Histone Deacetylase 1 Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Histone Deacetylase 1 Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Histone Deacetylase 1 Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Histone Deacetylase 1 Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Histone Deacetylase 1 Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Histone Deacetylase 1 Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Histone Deacetylase 1 Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Histone Deacetylase 1 Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Histone Deacetylase 1 Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Histone Deacetylase 1 Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Histone Deacetylase 1 Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Histone Deacetylase 1 Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Histone Deacetylase 1 Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Histone Deacetylase 1 Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Histone Deacetylase 1 Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Histone Deacetylase 1 Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Histone Deacetylase 1 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 4SC AG
  2. 8.1.1 4SC AG Company Information
  3. 8.1.2 4SC AG Business Overview
  4. 8.1.3 4SC AG Histone Deacetylase 1 Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 4SC AG Histone Deacetylase 1 Product Portfolio
  6. 8.1.5 4SC AG Recent Developments
  7. 8.2 Acetylon Pharmaceuticals, Inc.
  8. 8.2.1 Acetylon Pharmaceuticals, Inc. Company Information
  9. 8.2.2 Acetylon Pharmaceuticals, Inc. Business Overview
  10. 8.2.3 Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 Product Portfolio
  12. 8.2.5 Acetylon Pharmaceuticals, Inc. Recent Developments
  13. 8.3 Chipscreen Biosciences Ltd
  14. 8.3.1 Chipscreen Biosciences Ltd Company Information
  15. 8.3.2 Chipscreen Biosciences Ltd Business Overview
  16. 8.3.3 Chipscreen Biosciences Ltd Histone Deacetylase 1 Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Chipscreen Biosciences Ltd Histone Deacetylase 1 Product Portfolio
  18. 8.3.5 Chipscreen Biosciences Ltd Recent Developments
  19. 8.4 Curis, Inc.
  20. 8.4.1 Curis, Inc. Company Information
  21. 8.4.2 Curis, Inc. Business Overview
  22. 8.4.3 Curis, Inc. Histone Deacetylase 1 Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Curis, Inc. Histone Deacetylase 1 Product Portfolio
  24. 8.4.5 Curis, Inc. Recent Developments
  25. 8.5 HitGen LTD
  26. 8.5.1 HitGen LTD Company Information
  27. 8.5.2 HitGen LTD Business Overview
  28. 8.5.3 HitGen LTD Histone Deacetylase 1 Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 HitGen LTD Histone Deacetylase 1 Product Portfolio
  30. 8.5.5 HitGen LTD Recent Developments
  31. 8.6 IRBM Science Park SpA
  32. 8.6.1 IRBM Science Park SpA Company Information
  33. 8.6.2 IRBM Science Park SpA Business Overview
  34. 8.6.3 IRBM Science Park SpA Histone Deacetylase 1 Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 IRBM Science Park SpA Histone Deacetylase 1 Product Portfolio
  36. 8.6.5 IRBM Science Park SpA Recent Developments
  37. 8.7 Italfarmaco S.p.A.
  38. 8.7.1 Italfarmaco S.p.A. Company Information
  39. 8.7.2 Italfarmaco S.p.A. Business Overview
  40. 8.7.3 Italfarmaco S.p.A. Histone Deacetylase 1 Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Italfarmaco S.p.A. Histone Deacetylase 1 Product Portfolio
  42. 8.7.5 Italfarmaco S.p.A. Recent Developments
  43. 8.8 MEI Pharma, Inc.
  44. 8.8.1 MEI Pharma, Inc. Company Information
  45. 8.8.2 MEI Pharma, Inc. Business Overview
  46. 8.8.3 MEI Pharma, Inc. Histone Deacetylase 1 Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 MEI Pharma, Inc. Histone Deacetylase 1 Product Portfolio
  48. 8.8.5 MEI Pharma, Inc. Recent Developments
  49. 8.9 Mirati Therapeutics Inc.
  50. 8.9.1 Mirati Therapeutics Inc. Company Information
  51. 8.9.2 Mirati Therapeutics Inc. Business Overview
  52. 8.9.3 Mirati Therapeutics Inc. Histone Deacetylase 1 Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Mirati Therapeutics Inc. Histone Deacetylase 1 Product Portfolio
  54. 8.9.5 Mirati Therapeutics Inc. Recent Developments
  55. 8.10 Oncolys BioPharma Inc.
  56. 8.10.1 Oncolys BioPharma Inc. Company Information
  57. 8.10.2 Oncolys BioPharma Inc. Business Overview
  58. 8.10.3 Oncolys BioPharma Inc. Histone Deacetylase 1 Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Oncolys BioPharma Inc. Histone Deacetylase 1 Product Portfolio
  60. 8.10.5 Oncolys BioPharma Inc. Recent Developments
  61. 8.11 Sigma-Tau S.p.A.
  62. 8.11.1 Sigma-Tau S.p.A. Company Information
  63. 8.11.2 Sigma-Tau S.p.A. Business Overview
  64. 8.11.3 Sigma-Tau S.p.A. Histone Deacetylase 1 Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Sigma-Tau S.p.A. Histone Deacetylase 1 Product Portfolio
  66. 8.11.5 Sigma-Tau S.p.A. Recent Developments
  67. 8.12 Syndax Pharmaceuticals, Inc.
  68. 8.12.1 Syndax Pharmaceuticals, Inc. Company Information
  69. 8.12.2 Syndax Pharmaceuticals, Inc. Business Overview
  70. 8.12.3 Syndax Pharmaceuticals, Inc. Histone Deacetylase 1 Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Syndax Pharmaceuticals, Inc. Histone Deacetylase 1 Product Portfolio
  72. 8.12.5 Syndax Pharmaceuticals, Inc. Recent Developments
  73. 8.13 TetraLogic Pharmaceuticals
  74. 8.13.1 TetraLogic Pharmaceuticals Company Information
  75. 8.13.2 TetraLogic Pharmaceuticals Business Overview
  76. 8.13.3 TetraLogic Pharmaceuticals Histone Deacetylase 1 Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 TetraLogic Pharmaceuticals Histone Deacetylase 1 Product Portfolio
  78. 8.13.5 TetraLogic Pharmaceuticals Recent Developments
  79. 8.14 GlaxoSmithKline Plc
  80. 8.14.1 GlaxoSmithKline Plc Company Information
  81. 8.14.2 GlaxoSmithKline Plc Business Overview
  82. 8.14.3 GlaxoSmithKline Plc Histone Deacetylase 1 Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 GlaxoSmithKline Plc Histone Deacetylase 1 Product Portfolio
  84. 8.14.5 GlaxoSmithKline Plc Recent Developments
  85. 8.15 Merck & Co., Inc.
  86. 8.15.1 Merck & Co., Inc. Company Information
  87. 8.15.2 Merck & Co., Inc. Business Overview
  88. 8.15.3 Merck & Co., Inc. Histone Deacetylase 1 Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Merck & Co., Inc. Histone Deacetylase 1 Product Portfolio
  90. 8.15.5 Merck & Co., Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Histone Deacetylase 1 Value Chain Analysis
  2. 9.1.1 Histone Deacetylase 1 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Histone Deacetylase 1 Sales Mode & Process
  6. 9.2 Histone Deacetylase 1 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Histone Deacetylase 1 Distributors
  9. 9.2.3 Histone Deacetylase 1 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst